A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

23.9K views

⸱

DOI:

10.3791/51019

⸱

March 17th, 2014

 ,  ,  , 

In This Article

Summary

We describe the agar-beads method to establish persistent long-term chronic Pseudomonas aeruginosa airway infection in the mouse model.

Abstract

A mouse model of chronic airway infection is a key asset in cystic fibrosis (CF) research, although there are a number of concerns regarding the model itself. Early phases of inflammation and infection have been widely studied by using the Pseudomonas aeruginosa agar-beads mouse model, while only few reports have focused on the long-term chronic infection in vivo. The main challenge for long term chronic infection remains the low bacterial burden by P. aeruginosa and the low percentage of infected mice weeks after challenge, indicating that bacterial cells are progressively cleared by the host.

This paper presents a method for obtaining efficient long-term chronic infection in mice. This method is based on the embedding of the P. aeruginosa clinical strains in the agar-beads in vitro, followed by intratracheal instillation in C57Bl/6NCrl mice. Bilateral lung infection is associated with several measurable read-outs including weight loss, mortality, chronic infection, and inflammatory response. The P. aeruginosa RP73 clinical strain was preferred over the PAO1 reference laboratory strain since it resulted in a comparatively lower mortality, more severe lesions, and higher chronic infection. P. aeruginosa colonization may persist in the lung for over three months. Murine lung pathology resembles that of CF patients with advanced chronic pulmonary disease.

This murine model most closely mimics the course of the human disease and can be used both for studies on the pathogenesis and for the evaluation of novel therapies.

Introduction

Cystic fibrosis (CF) is a genetic disease caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. This gene encodes for a chloride channel expressed on the membrane of most epithelial cells. Bronchiectasis, mucus plugging and parenchymal destruction caused mainly by Pseudomonas aeruginosa infections progressively lead to severe lung disease and mortality in most of the CF patients1. Understanding CF pathogenesis and further development of novel therapies rely on animal model with characteristic features of CF. Several mice, genetically modified for the Cftr gene, have been generated, but limitat....

Access restricted. Please log in or start a trial to view this content.

Protocol

1. Preparing Bacteria for Chronic Infection (Three and Two Days prior to Mouse Challenge)

  1. Select the appropriate P. aeruginosa strain to be tested.
  2. Inoculate a loopful of P. aeruginosa from a -80 °C stock culture to a Trypticase Soy Agar (TSA) plate and incubate at 37 °C overnight.
  3. Pick a single colony and inoculate into 5 ml Trypticase Soy Broth (TSB) in a 15 ml snap-capped tube and incubate at 37 °C overnight in a shaking incubator at 200 rpm.

2. Embedding Bacteria in Agar Beads for Chronic Infection (One Day prior to Infection)

  1. Take a small aliquot of bacterial overnigh....

Access restricted. Please log in or start a trial to view this content.

Results

When the protocol is done correctly, the P. aeruginosa agar-beads will measure between 100-200 µm and can be observed with an inverted light microscope by pipetting a small volume of the agar-beads suspension on a slide. Single bacterial cells are visible in the agar beads, as shown in detail in Figure 1.

The choice of P. aeruginosa strain used in the agar-beads preparation is critical. Figure 2 and Table 1 show the data obta.......

Access restricted. Please log in or start a trial to view this content.

Discussion

The critical steps in the P. aeruginosa-beads preparation and mouse challenge are reported below.

The P. aeruginosa strain used for mice challenge is critical. Mortality, chronic infection or clearance may differ significantly depending on the bacterial strain used for the challenge. The P. aeruginosa RP73 clinical strain was preferred over the PAO1 reference laboratory strain since it resulted in a comparatively lower mortality, more severe lesions, and higher chron.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors declare that they have no competing financial interests.

Acknowledgements

Research in Bragonzi’s laboratory has been funded by the Italian Cystic Fibrosis Foundation (CFaCore) and EU-F7-2009-223670. Part of this work was carried out in ALEMBIC, an advanced microscopy laboratory, and mouse histopathology was performed in the Unit of Pathological Anatomy (San Raffaele Scientific Institute).

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
Bacto Tryptic Soy BrothBecton Dickinson211823
Difco Agar, granulatedBecton Dickinson214510
Heavy mineral oilSigma-Aldrich330760-1L
S-(+)-Ketamine hydrochlorideSigma-AldrichK1884
Xylazine hydrochlorideSigma-AldrichX1251
1 ml Syringe 25 G 5/8 in 0.5 mm x 16 mmPIC3071250300350
Catheter 22 G 0.9 mm x 25 mmBecton Dickinson381223
Graefe Forceps - 0.5 mm Tips CurvedFine Science Tools11152-10
Scissors, Iris, 11 cm, straightWorld Precision Instruments501758
Suture clipsFine Science Tools12040-01
Suture threadFine Science Tools18020-40
RPMI 1640LonzaBE12-167F
Complete protease inhibitor cocktailRoche11836145001
Fast-Read 102 Burker disposable chamberBiosigma390497
Tuerk solutionFluka93770
RBC lysis bufferBiolegend420301
Fetal bovine serumLonzaDE14-801F
EZ cytofunnelThermo ScientificA78710021
Superfrost ultra plus microscope slidesThermo ScientificJ3800AMNZ
Diff-Quik Romanowsky staining setMedion Diagnostics130832
Hexadecyltrimethylammonium chlorideSigma-Aldrich52366-10G
96-well EIA/RIA plateCostar3590
3,3’,5,5’- TetramethylbenzidineSigma-AldrichT8665-1L
Sulfuric acidSigma-Aldrich320501-1L
10% Neutral buffered formalinBio-Optica05-01005Q
Harris hematoxylin non PapanicolauBio-Optica05-M06004
Eosin plus alcoholic solutionBio-Optica05-M11007
Equipment
Shaking incubatorAmerex InstrumentsSteady Shake 757
Water bathGrantSUB14
HomogenizerYstral
Precision balanceKERN440-47N
CytocentrifugeThermo ScientificA78300003
Low Cost Heating Pad2biolLCHP
Homogenization probeYstral2366925(small)
Inverted optical microscopeZeissAxioplan2
Camera (microscope)ZeissAxiocam MRc5
Rotary microtomeLeicaRM2255

References

  1. Gibson, R., Burns, J. L., Ramsey, B. W. Pathophysiology and management of pulmonary infections in cystic fibrosis. Am. J. Respir. Crit. Care. 168, 918-951 (2003).
  2. Bragonzi, A. Murine models of acute and chronic lung infection with cystic fibrosis pathogens.

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Explore More Articles

Chronic InfectionMouse ModelAgar BeadsIntratracheal InstillationBronchoalveolar LavageLung PathologyBacterial LoadInflammatory ResponseCystic Fibrosis